Ironwood Pharmaceuticals Provides First Quarter 2013 Investor Update
4/23/2013 6:53:47 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) today provided an update on its first quarter 2013 and recent business activities.
“We and Forest have made significant process advancing LINZESS during the first few months of commercialization, and the positive response from patients and physicians is very encouraging,” said Tom McCourt, chief commercial officer and senior vice president, marketing and sales.
Help employers find you! Check out all the jobs and post your resume.